Arsenic trioxide targets miR-125b in glioma cells

Current Pharmaceutical Design

Volumn 20, Issue 33, 2014, Pages 5354-5361

  Chen, Sulian ^a   Zhu, Lihua ^a   Huang, Jing ^a   Cai, Ying ^a   Lu, Xiaohui ^a   Yang, Qingling ^a   Wu, Qiong ^a   Chen, Changjie ^a   Wang, Zhiwei ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

As2O3; Bak1; Glioma; Invasion; miR 125b

Indexed keywords

ARSENIC TRIOXIDE; MICRORNA 125B; PROTEIN BAK; ANTINEOPLASTIC AGENT; MICRORNA; MIRN125 MICRORNA, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL INVASION ASSAY; DOWN REGULATION; DRUG MECHANISM; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL CYCLE; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; HUMANS; MICRORNAS; OXIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84910089112     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140128204132     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Mrugala M M. Advances and challenges in the treatment of glioblastoma: a clinician's perspective. Discov Med 2013; 15: 221-30.
3. Zhou J. Arsenic trioxide: an ancient drug revived. Chin Med J (Engl) 2012; 125: 3556-60.
4. Lengfelder E, Hofmann W K, Nowak D. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 2012; 26: 433-42.
5. Zhao S, Tsuchida T, Kawakami K, Shi C, Kawamoto K. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. Int J Oncol 2002; 21: 49-55.
6. Kanzawa T, Zhang L, Xiao L, et al. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24: 980-91.
7. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63: 2103-8.
8. Chiu H W, Ho S Y, Guo H R, Wang Y J. Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 2009; 5: 472-83.
9. Kim E H, Yoon M J, Kim S U, et al. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res 2008; 68: 266-75.
10. Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K. Arsenic trioxidemediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett 2010; 292: 64-72.
11. Shi L, Zhang S, Feng K, et al. Micro RNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Int J Oncol 2012; 40: 119-29.
12. Wan Y, Fei X F, Wang Z M, et al. Expression of mi R-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 2012; 31: 207-14.
13. Xia H F, He T Z, Liu C M, et al. Mi R-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem 2009; 23: 347-58.
14. Jin Z, Xu S, Yu H, et al. mi R-125b Inhibits Connexin43 and Promotes Glioma Growth. Cell Mol Neurobiol 2013.
15. Xia J, Duan Q, Ahmad A, et al. Genistein inhibits cell growth and induces apoptosis through up-regulation of mi R-34a in pancreatic cancer cells. Curr Drug Targets 2012; 13: 1750-6.
16. Wang Z, Azmi A S, Ahmad A, et al. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Cancer Res 2009; 69: 2757-65.
17. Ma J, Cheng L, Liu H, et al. Genistein down-regulates mi R-223 expression in pancreatic cancer cells. Curr Drug Targets 2013; 14: 1150-6.
18. Dizaji M Z, Malehmir M, Ghavamzadeh A, Alimoghaddam K, Ghaffari S H. Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line. Neurochem Res 2012; 37: 370-80.
19. Zhou M, Liu Z, Zhao Y, et al. Micro RNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 2010; 285: 21496-507.
20. Breccia M, Lo-Coco F. Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease. Expert Opin Pharmacother 2012; 13: 1031-43.
21. Powell B L. Arsenic trioxide in acute promyelocytic leukemia: potion not poison. Expert Rev Anticancer Ther 2011; 11: 1317-9.
22. Hoffman E, Mielicki W P. Arsenic trioxide: impact on the growth and differentiation of cancer cells and possible use in cancer therapy. Postepy Hig Med Dosw (Online) 2013; 67: 817-27.
23. Nakamura S, Nagano S, Nagao H, et al. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLo S One 2013; 8: e69466.
24. Kasinski A L, Slack F J. Epigenetics and genetics. Micro RNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-64.
25. Cao Y, Yu S L, Wang Y, et al. Micro RNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 2011; 32: 179-88.
26. Meng X Z, Zheng T S, Chen X, et al. micro RNA expression alteration after arsenic trioxide treatment in Hep G-2 cells. J Gastroenterol Hepatol 2011; 26: 186-93.
27. Zhang Y, Wu J H, Han F, et al. Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of micro RNA-376a. Neoplasma 2013; 60: 247-53.
28. Gu J, Zhu X, Li Y, et al. mi RNA-21 regulates arsenic-induced antileukemia activity in myelogenous cell lines. Med Oncol 2011; 28: 211-8.